Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

268 recalls, newest first

Class II · Moderate risk

All Over-The-Counter

CGMP Deviations: Potential exposure to rodents and rodent activity in the distribution center.

Ongoing cGMP deviation Dollar Tree Distribution, Inc. D-0641-2022
Class II · Moderate risk

Methylphenidate Hydrochloride Chewable Tablets

Failed Tablet Specifications: Recall of this drug product was voluntarily initiated by the manufacturer due to a market complaint, which stated that a tablet in the sealed bottle was twice larger in size when compared to the remaining tablets. This complaint is second of its kind.

Ongoing Failed specification Rising Pharmaceuticals NDC 64980-221-01 D-0573-2022
Class II · Moderate risk

Lexette (halobetasol propionate)

CGMP Deviation: Difficulty dispensing/does not dispense or dispensing liquid instead of foam.

Ongoing cGMP deviation Mayne Pharma Inc NDC 51862-604-50 D-0387-2022

Recalls by year